5AM Ventures
5AM Ventures is a life-science focused investment firm founded in 2002 that funds and builds next-generation therapeutic and life-science companies. The firm emphasizes early-stage private therapeutics (with an emphasis on Series A) and operates a public equity strategy that invests in small- and mid-cap public and later-stage private biotech and life science companies. 5AM also runs an internal incubator (the 4:59 Initiative) to discover, incubate and fund breakthrough science and to establish proof-of-concept enabling Series A financings.
5AM Ventures
Services
Venture Capital Funding (Early-stage / Series A)
Provides equity funding focused primarily on early-stage private therapeutic companies, with emphasis on Series A financings.
Public Equity / Opportunities Strategy
Invests in small- and mid-cap public biotech and life science companies and later-stage private companies through a public equity strategy (5AM Opportunities).
4:59 Initiative — Incubation and Proof-of-Concept Support
A hands-on internal effort to discover, incubate, and fund breakthrough science. Partners alongside academics and entrepreneurs and often serves as an extension of the operating team to establish proof-of-concept data enabling Series A financing.
Venture Capital Funding (Early-stage / Series A)
Provides equity funding focused primarily on early-stage private therapeutic companies, with emphasis on Series A financings.
Public Equity / Opportunities Strategy
Invests in small- and mid-cap public biotech and life science companies and later-stage private companies through a public equity strategy (5AM Opportunities).
4:59 Initiative — Incubation and Proof-of-Concept Support
A hands-on internal effort to discover, incubate, and fund breakthrough science. Partners alongside academics and entrepreneurs and often serves as an extension of the operating team to establish proof-of-concept data enabling Series A financing.